The DOI matches its Crossref record; the references it cites are not checked yet.
Intranasal Steroids and Oral Leukotriene Modifier Therapy in Residual Sleep-Disordered Breathing After Tonsillectomy and Adenoidectomy in Children
Abstract
OBJECTIVE. Tonsillectomy and adenoidectomy (T&A) is the primary therapeutic approach for sleep-disordered breathing (SDB) in children. However, residual mild SDB will be found in more than one third of these patients after T&A. We hypothesized that combined therapy with the leukotriene receptor antagonist montelukast and intranasal budesonide would result in normalization of residual SDB after T&A. METHODS. During the period of October 2002 to February 2005, children who underwent T&A for SDB underwent a routine postoperative (second) overnight polysomnographic evaluation (PSG) 10 to 14 weeks after T&A surgery. In children with residual apnea hypopnea index (AHI) >1 and <5/hour of total sleep time (TST), treatment with montelukast and intranasal budesonide aqueous solution was administered for a period of 12 weeks (M/B group), at which time a third PSG was performed. Children who had residual SDB and did not receive M/B therapy from their treating physicians were recruited as control subjects. RESULTS. Twenty-two children received M/B, and 14 children served as control subjects. Mean age, gender distribution, ethnicity, and BMI were similar in the 2 treatment groups. The mean AHI at the second PSG was 3.9 ± 1.2/hour of TST and 3.6 ± 1.4/hour of TST in M/B-treated and control patients, respectively. Similar nadir arterial oxygen saturation (87.3 ± 1.2%) and respiratory arousal index (4.6 ± 0.7/hour of TST) were recorded for both groups. However, the M/B group demonstrated significant improvements in AHI (0.3 ± 0.3/hour of TST), in nadir arterial oxygen saturation (92.5 ± 3.0%), and in respiratory arousal index (0.8 ± 0.7/hour of TST) on the third PSG, whereas no significant changes occurred over time in control subjects. CONCLUSIONS. Combined anti-inflammatory therapy that consists of oral montelukast and intranasal budesonide effectively improves and/or normalizes respiratory and sleep disturbances in children with residual SDB after T&A.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“All included reports observed significant treatment-associated improvements in the AHI (mean pre-treatment AHI range 3.7–11 versus treatment-associated mean AHI range 0.3–6).”
From Non-CPAP therapies in obstructive sleep apnoea (2011) · cites this paper as [144]
In the citing paper
“The data are, however, inconsistent with respect to sleep architecture and adenoidal size (table e10) 140–145.”
From Non-CPAP therapies in obstructive sleep apnoea (2011) · cites this paper as [144]
In the citing paper
“and two studies demonstrated improved sleep quality.”
From Non-CPAP therapies in obstructive sleep apnoea (2011) · cites this paper as [144]
In the citing paper
“Three reports furthermore showed significant improvements in oxygenation indices”
From Non-CPAP therapies in obstructive sleep apnoea (2011) · cites this paper as [144]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 53 · Cited by 261
Research works printed but not linked: 1
- Tauman R, Montgomery-Downs HE, Ivanenko A, et al. Changes in sleep architecture and respiratory function following adenotonsillectomy in children with obstructive sleep apnea syndrome. Sleep. 2004(suppl);27:A100
Metadata
- Authors
- Kheirandish, L., Goldbart, A. D., & Gozal, D.
- Affiliations
- University of Louisville (US)
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2006-01-01
- Volume
- 117
- Issue
- 1
- Pages
- e61-e66
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2100191843
- Cited by
- 261
- References
- 53
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 10 · 2023: 6 · 2022: 7 · 2021: 14 · 2020: 10 · 2019: 11 · 2018: 16 · 2017: 11 · 2016: 23 · 2015: 14 · 2014: 19 · 2013: 15 · 2012: 19
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL-65 270, R01HL065270)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Surgery › Nasal Surgery and Airway Studies
- Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
- Keywords
- sleep-disordered breathing, adenotonsillectomy, children, montelukast, leukotriene receptor antagonists, anti-inflammatory therapy, apnea-hypopnea index, arterial oxygen saturation
- MeSH terms
- Acetates, Adenoidectomy, Administration, Intranasal, Administration, Oral, Child, Cyclopropanes, Drug Therapy, Combination, Female, Glucocorticoids, Humans, Male, Quinolines, Sleep Apnea Syndromes, Sulfides, Tonsillectomy, Polysomnography, Budesonide, Leukotriene Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intranasal Steroids and Oral Leukotriene Modifier Therapy in Residual Sleep-Disordered Breathing After Tonsillectomy and Adenoidectomy in Children. https://app.cochat.ai/papers/10.1542/peds.2005-0795
- The paper
- Kheirandish, L., Goldbart, A. D., & Gozal, D. (2006). Intranasal Steroids and Oral Leukotriene Modifier Therapy in Residual Sleep-Disordered Breathing After Tonsillectomy and Adenoidectomy in Children. Pediatrics. https://doi.org/10.1542/peds.2005-0795
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.